EXPERIMENTALLY-INDUCED MYCOPLASMA-PNEUMONIAE PNEUMONIA IN CHIMPANZEES

被引:10
|
作者
BARILE, MF
GRABOWSKI, MW
KAPATAISZOUMBOS, K
BROWN, B
HU, PC
CHANDLER, DKF
机构
[1] PRIMATE RES INST,HOLLOMAN AFB,NM 88330
[2] UNIV N CAROLINA,SCH MED,DEPT PEDIAT,CHAPEL HILL,NC 27514
关键词
MYCOPLASMA-PNEUMONIAE; CHIMPANZEE; PRIMARY ATYPICAL PNEUMONIA; PATHOGENESIS; IMMUNOLOGICAL RESPONSE;
D O I
10.1006/mpat.1993.1075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eight chimpanzees were examined. Two served as negative control and six inoculated with Mycoplasma pneumoniae became colonized. Colonization persisted for 28-68, 16-50 and 21 days with an average duration of 47, 32.5 and 21 days in the oropharyngeal, tracheal and lung tissues, respectively. Mycoplasma titers ranged from 108 to 101 color-changing units per specimen during the course of the infections. Seroconversion occurred within 12-15 days and peak antibody titers ranged from 1.256 to 1.1024 and developed between days 28 and 48 post-inoculation. Positive cold agglutinin titers were detected between 12 to 15 days and peak titers ranged from 1:80 to 1:640. Significant increases in sIgA and IgG immunoglobulin antibody levels were detected in lung lavage fluids. Unlike the many other experimentally infected animals examined, chimpanzees infected with M. pneumoniae had positive X-ray findings, developed cold agglutinins and showed overt signs of disease. These signs include persistent cough, low grade fever, rhinitis, oropharyngitis, diarrhea, and loss of appetite. Peak severity of disease corresponded with peak lung colonization, and the detection of cold agglutinins and positive X-ray findings. The microbiological, serological and clinical aspects of pneumonia induced in chimpanzees was similar to naturally occurring primary atypical pneumonia in humans. © 1993 Academic Press.
引用
收藏
页码:243 / 253
页数:11
相关论文
共 50 条
  • [31] MYCOPLASMA-PNEUMONIAE INFECTION PREDISPOSING TO STAPHYLOCOCCAL PNEUMONIA
    HENDERSON, A
    REID, D
    FREEMAN, R
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1983, 37 (02): : 75 - 76
  • [32] PROTECTION OF IMMUNIZED AND PREVIOUSLY INFECTED CHIMPANZEES CHALLENGED WITH MYCOPLASMA-PNEUMONIAE
    BARILE, MF
    GRABOWSKI, MW
    KAPATAISZOUMBOIS, K
    BROWN, B
    HU, PC
    CHANDLER, DKF
    VACCINE, 1994, 12 (08) : 707 - 714
  • [33] MYCOPLASMA-PNEUMONIAE
    PHILLIPS, DM
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (21): : 1421 - 1421
  • [34] MYCOPLASMA-PNEUMONIAE
    SILLIS, M
    LANCET, 1991, 337 (8749): : 1101 - 1101
  • [35] DEPRESSED CELLULAR-IMMUNITY IN MYCOPLASMA-PNEUMONIAE PNEUMONIA
    TSUNEKAWA, H
    TAKAGI, E
    KISHIMOTO, H
    SHIMOKATA, K
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1987, 70 (05): : 293 - 299
  • [36] COMPARISON OF JOSAMYCIN AND ERYTHROMYCIN IN THERAPY OF MYCOPLASMA-PNEUMONIAE PNEUMONIA
    WENZEL, RP
    HENDLEY, JO
    DODD, WK
    GWALTNEY, JM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (06) : 899 - 901
  • [37] CLINICAL-STUDIES ON PNEUMONIA CAUSED BY MYCOPLASMA-PNEUMONIAE
    OBANA, M
    KOBAYASHI, Y
    FUJIMORI, I
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 1983, 56 (5-6): : 871 - 872
  • [38] PROLONGED FEVER WITHOUT PNEUMONIA DUE TO MYCOPLASMA-PNEUMONIAE
    LEMERCIER, Y
    DECAZES, JM
    MECHALI, D
    COULAUD, JP
    NOUVELLE PRESSE MEDICALE, 1978, 7 (41): : 3772 - 3772
  • [39] PREVALENCE OF MYCOPLASMA-PNEUMONIAE IN CHILDREN WITH PNEUMONIA IN ZARIA, NIGERIA
    MIRZA, F
    AHMAD, AA
    IFERE, OAS
    YAKUBU, AM
    ANNALS OF TROPICAL PAEDIATRICS, 1991, 11 (01): : 51 - 55
  • [40] FACIAL DIPLEGIA AFTER PNEUMONIA CAUSED BY MYCOPLASMA-PNEUMONIAE
    MONTALBAN, J
    ALEMANY, ML
    MOLINS, A
    SUMALLA, J
    MEDICINA CLINICA, 1986, 86 (16): : 698 - 699